Khalid AlSulaiman
Chairman of the Board of Directors
Dr. Khalid A. Alsulaiman is a consultant critical care clinical pharmacist and an assistant professor in pharmacy practice. Currently, he serves as the program director for critical care pharmacy residency at King Abdulaziz Medical City in Riyadh. Dr. Alsulaiman completed his bachelor’s degree in pharmaceutical sciences from King Saud University (KSU) in 2011, followed by postgraduate studies at King Abdulaziz Medical City. He completed PGY-1 in 2013 and PGY-2 in critical care in 2016, becoming a board-certified critical care pharmacist by both American and Saudi councils. Additionally, he acquired American board certification in nutritional support in 2018 and is a board-certified nutritional support pharmacist. Dr. Alsulaiman furthered his education by obtaining a Master of Business Administration (MBA) degree from a Swiss Business School in 2021. He was designated as a fellow in the American College of Critical Care Medicine (FCCM) in 2022 and graduated from the Global Clinical Scholars Research Training (GCSRT) Program from Harvard Medical School, United States, in 2023.
Abdullah Al-Harthi
Financial Supervisor
Dr.Abdullah is the head of the Clinical Pharmacy department and an Assistant Professor of Clinical Pharmacy at Shaqra University. Also, he is a Critical Care clinical pharmacist. Dr.Abdullah completed his PharmD in 2017 from Taif University. Then, he joined King Abdulaziz Medical City- National Guard Health Affairs as a PGY1 resident in 2018. After that, in 2021, he completed his PGY2 in critical care at KAMC-Ryiadh. Dr.Abdullah is a dual American board-certified specialist in pharmacotherapy and critical care.
Aisha Al-Harbi
Board Member
Aisha Alharbi is an Infectious Disease Clinical Pharmacist and a certified Research Trainer (TOT). She serves as the Deputy Director of the Infectious Disease Pharmacy Residency Program at King Abdulaziz Medical City-Jeddah. Aisha completed her PharmD at King Abdulaziz University, graduating with the 1st Honorary Degree in 2018. She then pursued her PGY1 Pharmacy Residency at King Abdulaziz University Hospital and her PGY2 Pharmacy Residency in Infectious Disease at King Abdulaziz Medical City-Western Region. Aisha is certified by both the Saudi Board and the American Board of Infectious Disease (BCIDP).
Throughout her career, she has published several articles in reputable journals and has received multiple research awards during her internship and residency. Aisha has also conducted various research training courses in Jeddah, Riyadh, and Medina, and has organized several research schools that trained students from different medical fields.
Mai Alalawi
Board Member
Dr. Mai Alalawi is a hematology/oncology clinical pharmacist. She completed her PharmD degree from King Abdulaziz University in 2018 with 1st-degree honors. In 2021, she graduated from the International Pharmacy Practice Residency Program (ASHP accredited) at Children’s Cancer Hospital Cairo (57357) and then she pursued her career in the oncology field and earned the Saudi and the American board in Hematology/oncology clinical pharmacy after completing her training at King Abdulaziz Medical City- western region.
Mashael Al-Afifi
Board Member
Dr. Mashael AlFaifi is critical care clinical pharmacist at King Saud Medical City (KSMC). Dr. Mashael received her PharmD degree from Jazan University in 2018. Shortly after graduation, she joined and completed PGY-1 residency program at King Saud Medical City (KSMC) in (2021). Additionally, she has been certified by the American Board as a Pharmacotherapy Specialist. In 2022, Dr.Mashael complete her PGY-2 in Critical care residency program at King Abdulaziz Medical City- National guard health affairs (KAMC-CR).
Samiah Al-Sohimi
Board Member
Dr. Samiah Alsohimi is a Critical Care Clinical Pharmacist Specialist with a strong foundation in research and education. She currently serves as the Pharmacy Residency Program Director at King Fahad Armed Forces Hospital in Jeddah. Dr. Alsohimi completed both PGY1 and PGY2 pharmacy residency programs, specializing in critical care pharmacotherapy. Additionally, an American Board-certified in critical care pharmacotherapy.
She also holds a certificate in Generative Artificial Intelligence and has completed multiple advanced courses in AI, machine learning, digital transformation, and responsible technology use.
Dr. Alsohimi also serves as the Deputy Chief Editor of the SCAPE Journal. She has authored several peer-reviewed publications in the field of critical care, with research interests that include infectious diseases, cardiology, quality improvement, and medical education.
Asma Al-Shehri
Board Member
Dr. Alshehri is a critical care clinical pharmacist. Her professional journey in pharmacy began in 2018 after graduating from King Khalid University.Then she completed her Pharmacy Residency Program (PGY1) at Security Forces Hospital in Riyadh, followed by a PGY2 in Critical Care Specialty at National Guard Gealth Affairs, Riyadh, Saudi arabia, in 2023. She is an american board-certified pharmacotherapy specialist. Dr. Alshehri is actively engaged in various projects related to patient care and education, with several publications in the field of Intensive Care Unit (ICU) practices. Her research areas of interest include critical care, infectious disease, cardiology, and medical education.
Abeer A. Alenazi
Board Member
Abeer Alenazi is a hematology/oncology pharmacist at Prince Sultan Military Medical City. As of 2019, she has received her Pharm.D. from AlMaarefa University’s College of Pharmacy. Upon graduation, she gained two years of experience as a product specialist for GSK. Additionally, she has participated in research workshops and served on various committees. Following that, she completed a postgraduate pharmacy residency at Prince Sultan Military Medical City under the Saudi Board Postgraduate (PGY1) Pharmacy Residency (ASHP) accreditation.
